ArticleBMJ public health2026
Psychological burden in Indian adults with type 2 diabetes: prevalence, overlap and predictors of diabetes distress, depression and anxiety - a cross-sectional study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite growing recognition of the mental health consequences of type 2 diabetes (T2D), the prevalence, overlap and associated factors of psychological burden-encompassing diabetes distress (DD), depression and anxiety remain underexplored in the Indian population. This study aimed to examine these dimensions among Indian adults with T2D. Research design and methods: This cross-sectional study included 1925 adults (≥18 years) with T2D enrolled in an online diabetes management programme at the Freedom from Diabetes Clinic, Pune, India (December 2023 to December 2024). Socio-demographic, anthropometric, clinical and biochemical data were recorded. DD, depression and anxiety were measured using the Type 2 Diabetes Distress Assessment System, Patient Health Questionnaire-9 and Generalised Anxiety Disorder-7, respectively. Multivariable logistic regression identified factors independently associated with each outcome; results were interpreted using effect size (Cohen's d) to prioritise clinical significance. Results: DD was the most prevalent condition (53.1%), followed by depression (20.3%) and anxiety (17.3%). Substantial comorbidity was observed: 7.5% experienced all three conditions simultaneously, while 42.3% remained symptom-free. Depression and anxiety showed a strong intercorrelation (ρ=0.692), with moderate correlations between DD and both conditions (ρ=0.460-0.466). Absence of prior depression history was the strongest factor associated with psychological burden across all outcomes (adjusted OR (AOR)/Firth OR: DD=50.44, depression=2.11, anxiety=2.24; all p<0.001), though the large AOR for DD reflects quasi-complete separation; Firth's penalised regression yielded a consistent estimate (OR=42.67, p<0.001). The anxiety model required Firth's penalised regression as the primary method due to non-convergence in standard logistic regression caused by quasi-complete separation. Both DD and anxiety findings are presented as hypothesis-generating. Depression and anxiety were strongly co-associated (AORs >13.0). Additional factors associated with burden included younger age (<45 years), female sex, poor glycaemic control and insulin use. Conclusion: Indian adults with T2D experience substantial, overlapping psychological burden. These findings support the integration of routine, comprehensive mental health screening using validated tools into diabetes care, with particular attention to individuals without prior mental health history.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.